GILD Filing
4Filing Date: Jun 2, 2026

GILEAD SCIENCES, INC. (GILD) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001638643-26-000022open_in_new
Total Value$1.97M
Trades3
Insiders1

Transaction Details

O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Sell · Dispose
Common Stock
Shares-10.90K
Price$131.10
Total Value$1.43M
Shares Owned After621.67K
Transaction DateJun 1, 2026
10b5-1
Footnotes ▸

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. | Sale prices for the transactions reported range from $130.66 to $131.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Sell · Dispose
Common Stock
Shares-1.04K
Price$132.97
Total Value$138.0K
Shares Owned After617.57K
Transaction DateJun 1, 2026
10b5-1
Footnotes ▸

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. | Sale prices for the transactions reported range from $132.71 to $133.295. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Sell · Dispose
Common Stock
Shares-3.06K
Price$132.22
Total Value$404.8K
Shares Owned After618.61K
Transaction DateJun 1, 2026
10b5-1
Footnotes ▸

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. | Sale prices for the transactions reported range from $131.71 to $132.70. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Post-Transaction Holdings

O'Day Daniel Patrick
SecuritySharesChange
Common Stock621.67K-15.00K (-2.36%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-01 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: GILEAD SCIENCES, INC. (GILD) CIK: 0000882095 --- Reporting Owner --- Name: O'Day Daniel Patrick CIK: 0001638643 Role: Director, Officer (Chairman & CEO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-01 | Code: S (Open market sale) Shares: -10,900 | Price: $131.10 Total Value: $1,428,983.46 Shares Owned After: 621,667 | Ownership: D (Direct) Footnotes: [F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. [F2] Sale prices for the transactions reported range from $130.66 to $131.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. [Transaction #2] Security: Common Stock Date: 2026-06-01 | Code: S (Open market sale) Shares: -3,062 | Price: $132.22 Total Value: $404,842.64 Shares Owned After: 618,605 | Ownership: D (Direct) Footnotes: [F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. [F3] Sale prices for the transactions reported range from $131.71 to $132.70. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. [Transaction #3] Security: Common Stock Date: 2026-06-01 | Code: S (Open market sale) Shares: -1,038 | Price: $132.97 Total Value: $138,020.58 Shares Owned After: 617,567 | Ownership: D (Direct) Footnotes: [F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. [F4] Sale prices for the transactions reported range from $132.71 to $133.295. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. --- Footnotes (Complete Index) --- F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2: Sale prices for the transactions reported range from $130.66 to $131.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3: Sale prices for the transactions reported range from $131.71 to $132.70. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4: Sale prices for the transactions reported range from $132.71 to $133.295. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. --- Signature --- /s/ /s/ Amy Kim by Power of Attorney for Daniel O'Day (2026-06-02)

keid analysis is for reference only and does not constitute investment advice.